M&A

US asks Roche for more information related to $5.7B hostile takeover bid for Illumina
Yahoo/AP
Wed, 03/14/12 - 10:51 am
Roche
Illumina
hostile bid
M&A
ActiveCare Acquires 4G Biometrics in Move to Address Growing Needs of Diabetic Patients and Their Families
Tue, 03/13/12 - 10:51 pm
ActiveCare
4G Biometrics
M&A
A Med-Tech Shopping List For Japanese Companies
Tue, 03/13/12 - 10:50 pm
med-tech
Japan
M&A
Masimo acquires assets of Spire Semiconductor
Mon, 03/12/12 - 10:32 pm
Masimo
M&A
Spire Semiconductor
Syneron to Acquire Assets of TransPharma Medical Ltd.
Mon, 03/12/12 - 10:30 pm
Syneron
TransPharma
M&A
Asahi Kasei of Japan to Buy Zoll Medical for $2.2 Billion
Mon, 03/12/12 - 10:28 pm
Asahi Kasei
ZOLL Medical
Japan
M&A
Anaysis - AstraZeneca gets serious on deals as drugs run out
Reuters
Fri, 03/9/12 - 10:45 am
M&A
AstraZeneca
Celgene completes acquisition of Avila Therapeutics
Yahoo/Fly on the Wall
Thu, 03/8/12 - 10:11 am
Celgene
M&A
Avila
Bayer Considers Bid for Pfizer Animal-Health Unit
Bloomberg
Wed, 03/7/12 - 03:29 pm
Pfizer
Bayer
animal health
M&A
GlaxoSmithKline resumes search for consumer drugs buyer, Reuters says
Yahoo/Fly on the Wall
Wed, 03/7/12 - 10:37 am
GSK
OTC
M&A
CareFusion to acquire PHACTS
Tue, 03/6/12 - 10:30 pm
CareFusion
PHACTS
M&A
Roche sees alternatives to Illumina if bid fails
Reuters
Tue, 03/6/12 - 11:12 am
Roche
Illumina
hostile bid
M&A
Roche's Illumina Bid Gets More Time
Yahoo/Zacks
Sat, 03/3/12 - 11:17 am
Roche
Illumina
M&A
Syneron Closes Acquisition of Ultrashape Ltd.
Fri, 03/2/12 - 05:33 pm
Syneron
Ultrashape
M&A
Discount Dental Materials, Inc. Acquires Cerebain Biotech Corp.
Fri, 03/2/12 - 05:25 pm
Discount Dental
Cerebain
M&A
Judge refuses to halt Amgen-Micromet deal
Yahoo/AP
Thu, 03/1/12 - 06:03 pm
Amgen
Micromet
M&A
Recent FDA Approval Makes Vertex A Ripe Target For Takeover
Seeking Alpha
Thu, 03/1/12 - 12:45 pm
FDA
Vertex
M&A
Kalydeco
cystic fibrosis
STAAR Surgical initiated with a Buy at Canaccord
Wed, 02/29/12 - 10:38 pm
Staar Surgical
M&A
Galapagos looking for acquisitions after drug deal
Reuters
Wed, 02/29/12 - 11:02 am
Abbott Laboratories
M&A
Galapagos
Obesity Epidemic Prompting Vivus Takeover Talk With 68% Windfall: Real M&A
Bloomberg
Wed, 02/29/12 - 10:12 am
obesity
M&A
Vivus
Qnexa
JNJ
Merck
Bristol-Myers Squibb
Arena Pharmaceuticals
Orexigen

Pages